#54: Current state of surgical revascularization in patients with CAD with Dr Timothy Gardner

Dr Robert Harrington


January 08, 2013

This feature requires the newest version of Flash. You can download it here.

The FREEDOM trial has added a wealth of data to the debate on revascularization in patients with heart disease. Dr Timothy Gardner joins the show to discuss the revascularization options, what we have learned from FREEDOM, BARI, BARI 2D, and PREVENT, ad hoc PCI, the role of the heart team, and why collaboration between interventionalist and CV surgeon is the way of the future.

Timothy Gardner MD
Professor, Thomas Jefferson University
Medical Director, Center for Heart and Vascular
Executive Director, Value Institute
Christiana Care Health System
Newark, DE

Robert Harrington MD
Arthur L Bloomfield Professor of Medicine and Chair
Department of Medicine
Stanford University
Stanford, CA

Dr Gardner has served as the steering committee chair for the Cardiothoracic Clinical Research Network.

For Dr Harrington's disclosures, click here.

See also:


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.